首页> 外文期刊>生物医学研究杂志(英文版) >A comparative genomics analysis of lung adenocarcinoma for Chinese population by using panel of recurrent mutations
【24h】

A comparative genomics analysis of lung adenocarcinoma for Chinese population by using panel of recurrent mutations

机译:用复发性突变小组对中国人群肺腺癌的比较基因组学分析

获取原文
获取原文并翻译 | 示例
       

摘要

Previous studies have demonstrated that Chinese lung adenocarcinoma(LUAD)patients have unique genetic characteristics,however,the specific genomic features relating to the development and treatment of LUAD in the Chinese population are not fully understood.Here,we applied the ultra-deep targeted sequencing to 66 Chinese LUAD samples,accompanied by comparative analysis with 162 Caucasian LUAD in The Cancer Genome Atlas.We focused on the 68 recurrently mutated genes and results revealed that the panel-based tumor mutational burden(pTMB)is significantly higher in the Chinese LUAD(P=0.0017).Additionally,the percentage of smoking-associated C>A transversion is significantly lower in Chinese LUAD(15.5%vs.39.7%,P=5.69×10^(-27)),while C>T transition is more frequent in Chinese LUAD(35.8%vs.25.7%,P=2.67×10^(-5)),which indicated the ethnic difference in mutation types.Notably,novel driver genes(GNAS and JAK1)that are peculiar to Chinese LUAD were identified,and a more convergent distribution of mutations was observed in the Chinese cohort(P=0.012)compared with scattered mutations in Caucasian LUAD.Our results present a distinct genomic profile of Chinese LUAD compared to Caucasians LUAD and elucidate the ethnic difference in mutation distribution besides the type and rate.

著录项

  • 来源
    《生物医学研究杂志(英文版)》 |2021年第1期|11-20|共10页
  • 作者单位

    Department of Bioinformatics Nanjing Medical University Nanjing Jiangsu 211166 China;

    Department of Bioinformatics Nanjing Medical University Nanjing Jiangsu 211166 China;

    Department of Oncology the First Affiliated Hospital of Nanjing Medical University Nanjing Jiangsu 210029 China;

    Department of Oncology the First Affiliated Hospital of Nanjing Medical University Nanjing Jiangsu 210029 China;

    Department of Cell Biology School of Basic Medical Sciences Nanjing Medical University Nanjing Jiangsu 211166 China;

    Department of Bioinformatics Nanjing Medical University Nanjing Jiangsu 211166 China;

    Jiangsu Key Lab of Cancer Biomarkers Prevention and Treatment Collaborative Innovation Center for Cancer Personalized Medicine Nanjing Jiangsu 211166 China;

    Department of Oncology the First Affiliated Hospital of Nanjing Medical University Nanjing Jiangsu 210029 China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肺肿瘤;
  • 关键词

  • 入库时间 2022-08-19 04:56:33
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号